Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

RNA-seq03:21

RNA-seq

RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases. 
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while microarray-based...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>TERT</i> Promoter Mutations in Keratinizing and Nonkeratinizing Squamous Metaplasia of the Urinary Tract.

European urology open science·2022
Same author

Biochemical characterization of the interaction between KRAS and Argonaute 2.

Biochemistry and biophysics reports·2022
Same author

Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer.

Nature·2021
Same author

Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need.

Urology·2021
Same author

G3BP1 inhibits Cul3<sup>SPOP</sup> to amplify AR signaling and promote prostate cancer.

Nature communications·2021
Same author

Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer.

European urology oncology·2021
Same journal

Tau protein as a regulator of mitochondrial function and dynamics.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

A scalable, dividing cell model for the robust propagation and quantification of human sporadic Creutzfeldt-Jakob disease prions.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Epigenetic regulation of mesenchymal BMP signaling directs postnatal organ innervation.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Single-shot wide-field biochemical imaging at 1 kHz frame rate.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

Morphogenesis and topological evolution of a frustrated nematic liquid crystal under confinement.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same journal

B cell-intrinsic CXCR3 drives efficient generation of ectopic pulmonary germinal center responses to influenza A virus infection.

Proceedings of the National Academy of Sciences of the United States of America·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2026

Chromatin Interaction Analysis with Paired-End Tag Sequencing (ChIA-PET) for Mapping Chromatin Interactions and Understanding Transcription Regulation
21:55

Chromatin Interaction Analysis with Paired-End Tag Sequencing (ChIA-PET) for Mapping Chromatin Interactions and Understanding Transcription Regulation

Published on: April 30, 2012

Chimeric transcript discovery by paired-end transcriptome sequencing.

Christopher A Maher1, Nallasivam Palanisamy, John C Brenner

  • 1Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA.

Proceedings of the National Academy of Sciences of the United States of America
|July 14, 2009
PubMed
Summary
This summary is machine-generated.

Paired-end transcriptome sequencing effectively identifies novel cancer gene fusions. This sensitive method distinguishes key driver mutations from passenger ones, aiding therapeutic target discovery.

More Related Videos

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
11:52

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

Published on: August 4, 2016

Computational Analysis Tutorial for Chimeric Small Noncoding RNA: Target RNA Sequencing Libraries
07:35

Computational Analysis Tutorial for Chimeric Small Noncoding RNA: Target RNA Sequencing Libraries

Published on: December 1, 2023

Related Experiment Videos

Last Updated: Jun 21, 2026

Chromatin Interaction Analysis with Paired-End Tag Sequencing (ChIA-PET) for Mapping Chromatin Interactions and Understanding Transcription Regulation
21:55

Chromatin Interaction Analysis with Paired-End Tag Sequencing (ChIA-PET) for Mapping Chromatin Interactions and Understanding Transcription Regulation

Published on: April 30, 2012

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations
11:52

Targeted RNA Sequencing Assay to Characterize Gene Expression and Genomic Alterations

Published on: August 4, 2016

Computational Analysis Tutorial for Chimeric Small Noncoding RNA: Target RNA Sequencing Libraries
07:35

Computational Analysis Tutorial for Chimeric Small Noncoding RNA: Target RNA Sequencing Libraries

Published on: December 1, 2023

Area of Science:

  • Genomics
  • Cancer Biology
  • Molecular Diagnostics

Background:

  • Recurrent gene fusions are key cancer mutations that can create novel therapeutic targets.
  • Existing methods struggle to comprehensively identify all functional gene fusions.
  • A sensitive, high-throughput approach is needed to catalog these mutations.

Purpose of the Study:

  • To develop and evaluate a paired-end transcriptome sequencing strategy for comprehensive gene fusion detection in cancer.
  • To assess the sensitivity and specificity of this method for identifying driver and passenger fusions.
  • To discover novel gene fusions in cancer cell lines and patient tumors.

Main Methods:

  • Utilized paired-end transcriptome sequencing to analyze RNA.
  • Compared paired-end sequencing with single-read approaches.
  • Applied the method to identify gene fusions in cancer cell lines and prostate tumors.

Main Results:

  • Paired-end sequencing demonstrated a greater dynamic range than single-read methods.
  • This approach successfully differentiated high-level driver fusions from lower-level passenger fusions.
  • Discovered 12 novel gene fusions in cell lines and identified new ETS gene fusions in prostate tumors.
  • Observed various chimera types including read-through, tissue-restricted, converging, diverging, and overlapping transcripts.

Conclusions:

  • Paired-end transcriptome sequencing is a highly specific and sensitive method for cataloging gene fusions.
  • This approach enables comprehensive discovery of novel functional transcripts for cancer therapeutics.
  • The methodology advances the accurate identification of chimeras in biological samples.